Medical treatment in neurofibromatosis type 2. Review of the literature and presentation of clinical reports
{{output}}
The understanding of the molecular pathways underlying tumor development in neurofibromatosis type 2 (NF2) is increasing. Thus, repositioning drugs, drug therapies that are already clinically available for various cancers, appear potentially promising for NF2 ... ...
